Synapse - Find an Expert

11741 Results

Management of dysplastic nevi and melanomas

Book Section

Huang, C. L.; Marghoob, A. A.; Halpern, A. C.
In Robinson, J. K.; Hanke, C. W.; Sengelmann, R. D.; Siegel, D. M. (Eds.) Surgery of the Skin: Procedural Dermatology (2005)

Fulltext@MSK | Save

Modeling the clinical complexities of cancer chemoprevention

Meeting Abstract

Zauber, A. G.; Vogelaar, I.; Van Ballegooijen, M.; Boer, R.; Habbema, J. D. F.
Cancer Epidemiology Biomarkers and Prevention (2005)

Fulltext@MSK | Save

Cost-effectiveness of hepatic artery infusion for metastatic colorectal cancer (CALGB 9481)

Meeting Abstract

Weeks, J. C.; Romanus, D.; Herndon, J. E.; Schrag, D.; Mayer, R. J.; Kemeny, N.
Value in Health (2005)

Fulltext@MSK | Save

A randomized trial of cytarabine with high-dose mitoxantrone compared to a standard vincristine/prednisone-based regimen as induction therapy for adult patients with ALL

Meeting Abstract

Weiss, M. A.; Heffner, L.; Lamanna, N.; Kalaycio, M.; Schiller, G.; Coutre, S.; Maslak, P.; Jurcic, J.; Panageas, K.; Scheinberg, D. A.
Journal of Clinical Oncology (2005)

Fulltext@MSK | Save

A phase II trial of letrozole in combination with bevacizumab, an anti-VEGF antibody, in patients with hormone receptor-positive metastatic breast cancer

Meeting Abstract

Traina, T. A.; Dickler, M. N.; Caravelli, J. F.; Yeh, B. M.; Brogi, E.; Panageas, K.; Flores, S. A.; Norton, L.; Park, J.; Hudis, C.; more...
Breast Cancer Research and Treatment (2005)

Fulltext@MSK | Save

A feasibility study of an aromatase inhibitor (Al), letrozole (L) and the antibody to vascular endothelial growth factor (VEGF), bevacizurnab (B), in patients (pts) with hormone receptor-positive metastatic breast cancer (MBC)